BTK and uveitis: BTK inhibitors may cause uveitis through off-target immune modulation because BTK is expressed in myeloid cells and microglia; ibrutinib also inhibits ITK (important in T-cells) which could tilt immune responses and provoke ocular inflammation in susceptible individuals (17).